The main reason for the improvements in facing leukaemia is "the development of new treatments, combined with good levels of recruitment to UK clinical trials", according to the research's lead author.
Dr Anjali Shah, from the London School of Hygiene & Tropical Medicine and the University of Oxford, added:
These key issues have been effective in curing more people of acute myeloid leukaemia (AML).
But levels of cure of this disease in England remain lower than those observed in other European countries, such as Sweden.
The reasons for these differences are unknown.
More top news
Lucy Beale's killer will be revealed live on air during a special week of EastEnders episodes to mark the soap's 30th anniversary.
Spandau Ballet reunited on stage for the first time in five years as the band performed at the premiere of a film documenting their career.
From tomorrow, tax discs will no longer be needed to show drivers have paid their vehicle tax. Richard Pallot reports on the end of an era.